Clear market notes built around the JSE, the rand, and what matters locally.

2026-07-28 11:30 • The Motley Fool Positive Axe Cap view: Selective

Intuitive Surgical stock has declined 44% from its highs, but 71% of Wall Street analysts rate it as a buy with price targets suggesting up to 103% upside. The stock's valuation has fallen to 38-39x earnings, well below its historical 64-65x average, while the company's da Vinci 5 robotics platform continues gaining momentum with strong hospital adoption and recurring revenue from parts and services.

Axe note: Intuitive Surgical’s sharp pullback has pushed valuation to a rare discount, but is it a smart buy for local investors?

2026-07-28 11:15 • The Motley Fool Neutral Axe Cap view: Neutral

Norwegian Cruise Line reports Q2 earnings on July 30 after disappointing Q1 results and lowered full-year guidance due to higher fuel costs and weak European bookings. While the long-term investment case remains intact with plans for 16 new ships through 2037, investors should focus on management's execution progress on pricing and operations rather than beating quarterly estimates. The stock is suitable for long-term investors comfortable with volatility, but success depends on consistent earnings growth and debt reduction over several years.

Axe note: NCLH's long-term potential is overshadowed by short-term execution risks and no direct benefits for South African investors.

2026-07-28 11:12 • The Motley Fool Negative Axe Cap view: Neutral

Apple is set to report fiscal Q3 earnings on July 30 with analyst expectations of 16% revenue growth and 20% earnings growth. While the stock has hit all-time highs and shown strong momentum with a 58% gain over the past year, the author advises against buying before the earnings report, citing concerns about valuation (trading at 35x next fiscal year's earnings) and the cyclical nature of Apple's growth, which hasn't sustained double-digit revenue growth for consecutive years in the post-Jobs era.

Axe note: Apple’s impressive momentum masks valuation risks ahead of its July 30 earnings report.